Stock screener

LXRX

Conviction 47HealthcareScan · Thu, Sep 24, 2026

Lexicon Pharmaceuticals, Inc. (LXRX) closed at $1.85 (-10.19%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 33, RS Rating 82, -29.9% from its 52-week high, +62.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

LXRX$1.85-10.19%
ResistanceSupportVol 14
63 bars
Vol MA14 3.35M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
LEXICON PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.lexpharma.com ↗
Price1.85
Change-10.19%
Gap-0.97%
Rel volume3.09×
Avg volume3.18M
Avg $ vol6.65M
SMA 202.12
SMA 502.25
SMA 2001.83
Price vs 50-17.92%
Price vs 200+1.18%
MA stackmixed
50/200 cross—
Supertrenddown · 2.25
RSI (14)33
MACD hist-0.01
MACD crossbear · 0d
Stoch %K / %D0 / 41
ADX (14)37
+DI / −DI15 / 32
RSI divergence—
MACD divergence—
ATR %6.12%
ADR %4.57%
52w high2.64
52w low1.14
From 52w high-29.92%
Above 52w low+62.28%
New 52w highNo
SqueezeOff
Bollinger width23.74%
%B-0.04
Donchian pos0.00%
Donchian high2.34
Donchian low1.85
AVWAP (52w high)2.24
vs AVWAP high-17.49%
AVWAP (52w low)1.99
vs AVWAP low-6.83%
OBV trendDown
Chaikin MF (20)-0.02
Today vs 20d3.09×
Avg vol (14d)3.35M
Avg vol (20d)3.18M
Avg $ vol (20d)6.65M
Market cap823.17M
RS Rating82 / 99
RS 3m (vs SPY)-23.71%
RS 6m (vs SPY)-6.70%
RS line new highNo
Trend template4/8
Technical rank42.0
1 week-9.09%
1 month-20.94%
3 months-19.21%
6 months+10.12%
1 year+52.89%
YTD+62.28%
P/E-16.35
P/B4.72
P/S137.17
P/FCF-12.13
EPS-0.1400
Div yield—
ROE-28.84%
ROA-20.13%
Debt/Eq0.29
Current13.37
EV/EBITDA-17.26
Gross margin—
Net margin-838.88%
Rev growth440.63%
EPS growth74.88%
Price target5.03
Target upside171.89%
Analyst ratingBuy
Institutional84.58%
Ent. value833.68M
Revenue1.26M
Net income-31.77M
Gross profit—
Free cash flow-67.85M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out444.2M
Employees81
ListedFri, Apr 7, 2000
Free float158.98M
Float %43.7%
Short interest29.49M
Days to cover10.3d
Short volume45.5%
Squeeze score81 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.06 vs −$0.06
Last surprise0.0% beat
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank42.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.51
Support1.92
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LXRX

All disclosures →
No recent disclosed trades by Congress in LXRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LXRX

InsiderSideShares
BARKER SAM L
Director · Restricted Stock Units · 2026-06-03
Exercise89.31K
BARKER SAM L
Director · Common Stock · 2026-06-03
Exercise89.31K
DEBBANE RAYMOND
Director · Common Stock · 2026-06-03
Other—
SOBECKI CHRISTOPHER J
Director · Common Stock · 2026-06-03
Exercise89.31K
Amouyal Philippe
Director · Common Stock · 2026-06-03
Exercise89.31K
SOBECKI CHRISTOPHER J
Director · Restricted Stock Units · 2026-06-03
Exercise89.31K
Sullivan Diane E.
Director · Common Stock · 2026-06-03
Exercise89.31K
Amouyal Philippe
Director · Restricted Stock Units · 2026-06-03
Exercise89.31K
DEBBANE RAYMOND
Director · Common Stock · 2026-06-03
Exercise89.31K
Swain Judith L
Director · Common Stock · 2026-06-03
Exercise89.31K

SEC filings

EDGAR filings in LXRX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.